← Back to Search

GeriKit App for Ischemic Heart Disease

N/A

Recruiting

Led By John A. Dodson, MD, MPH, FACC

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Capable of self-consent

Age ≥ 75

Must not have

Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)

Non-ambulatory

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

No Placebo-Only Group

Summary

This trial will use an "app" to help better understand & care for older adults in different settings, improving research & care.

Who is the study for?

This trial is for individuals aged 75 or older who are currently hospitalized or were hospitalized within the past month for heart-related procedures like AMI, PCI, or CABG. Participants must be able to consent and perform study tasks in English. Those with severe cognitive issues, non-ambulatory status, incarceration, or inability to complete assessments in English cannot join.

What is being tested?

The trial is testing the GeriKit mobile application's effectiveness in assessing older adults with ischemic heart disease. The goal is to improve patient care and research by better understanding this population through the app's use.

What are the potential side effects?

Since this trial involves a mobile application rather than a medication, traditional side effects are not applicable. However, participants may experience difficulty using the app due to unfamiliarity with technology or discomfort related to engagement with their health condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am able to understand and agree to the study on my own.

Select...

I am 75 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with dementia.

Select...

I cannot walk by myself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Incidence of Mortality or Hospital Readmission

Secondary study objectives

12-Item Short Form Survey (SF-12) Score

Seattle Angina Questionnaire Short-Form (SAQ-7)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Geriatric Assessments using GeriKit AppExperimental Treatment1 Intervention

Participants will receive comprehensive geriatric assessment via GeriKit app at baseline. All participants will complete a follow-up assessment via phone at 6 months. 20 of the 150 enrolled participants will continue onto a qualitative questionnaire after the completion of the 6-month follow up call.

0 / 4Eligibility criteria met